YOUR BUSINESS AUTHORITY

Springfield, MO

Log in Subscribe

Eli Lilly records better-than-expected Q2 results

Posted online

Eli Lilly had better-than-expected results in the second quarter amid higher sales of Zepbound and Mounjaro.

Adjusted earnings per share were $3.92. Analysts expected $2.60 per share.

Revenue was reported at $11.3 billion. Analysts were looking for $9.9 billion.

Read more from CNBC.

Comments

No comments on this story |
Please log in to add your comment
Editors' Pick
Transportation officials discuss $471M Forward 44 initiative

Project work in Springfield corridor will continue into 2031.

Most Read
Update cookies preferences